Test Compendium
Test Compendium is your definitive resource for detailed information on a wide array of diagnostic tests. Each entry in our compendium is meticulously cataloged to aid healthcare providers in selecting and interpreting the right tests for their patients.
Displaying 76 - 100 of 352
Karyotyping Lymphoid - T-Cell
KaryotypingKaryotyping Lymphoid - T-Cell Methodology Karyotyping Test Description Probes/Genes - Disease Subtyping of lymphomas, leukemias and solid tumours for the purpose of exact diagnosis, treatment stratification
Karyotyping Lymphoid - B-Cell
KaryotypingKaryotyping Lymphoid - B-Cell Methodology Karyotyping Test Description Probes/Genes - Disease Subtyping of lymphomas, leukemias and solid tumours for the purpose of exact diagnosis, treatment stratification
PD-L1 FDA (KEYTRUDA®) for TNBC (Breast)
Immunohistochemistry (IHC)PD-L1 FDA (KEYTRUDA®) for TNBC (Breast) Methodology Immunohistochemistry (IHC) Test Description Probes/Genes PD-L1 Keytruda(22C3) Disease Breast cancerProgrammed cell death ligand 1 (PD-L1) is a predictive
PD-L1 FDA (KEYTRUDA®) for Esophageal SCC
Immunohistochemistry (IHC)PD-L1 FDA (KEYTRUDA®) for Esophageal SCC Methodology Immunohistochemistry (IHC) Test Description Probes/Genes PD-L1 Keytruda (22C3) Disease Esophagus Squamous Cell CarcinomaProgrammed cell death ligand
PD-L1 FDA (KEYTRUDA®) for Gastric/GEA
Immunohistochemistry (IHC)PD-L1 FDA (KEYTRUDA®) for Gastric/GEA Methodology Immunohistochemistry (IHC) Test Description Probes/Genes PD-L1 Keytruda(22C3) Disease Gastric CancerProgrammed cell death ligand 1 (PD-L1) is a predictive
PD-L1 FDA (KEYTRUDA®) for NSCLC
Immunohistochemistry (IHC)PD-L1 FDA (KEYTRUDA®) for NSCLC Methodology Immunohistochemistry (IHC) Test Description Probes/Genes PD-L1 Keytruda(22C3) Disease NSCLCIn NSCLC, checkpoint inhibitors represent a new class of drugs that
PD-L1 FDA (KEYTRUDA®) for Other Tumor Types
Immunohistochemistry (IHC)PD-L1 FDA (KEYTRUDA®) for Other Tumor Types Methodology Immunohistochemistry (IHC) Test Description Probes/Genes PD-L1 Keytruda(22C3) Disease Solid tumorsProgrammed cell death ligand 1 (PD-L1) is a predictive
PD-L1 FDA (KEYTRUDA®) for Urothelial
Immunohistochemistry (IHC)PD-L1 FDA (KEYTRUDA®) for Urothelial Methodology Immunohistochemistry (IHC) Test Description Probes/Genes PD-L1 Keytruda(22C3) Disease Urothelial CarcinomaDetection of PD-L1 upregulation in urothelial
Actin (Muscle Specific)/HHF35
Immunohistochemistry (IHC)Actin (Muscle Specific)/HHF35 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes MUSA IHC Disease useful as a marker for muscle and muscle-derived cells.This antibody recognizes actin
Actin (Smooth Muscle) (SMA)
Immunohistochemistry (IHC)Actin (Smooth Muscle) (SMA) Alternative Name Smooth Muscle Actin Methodology Immunohistochemistry (IHC) Test Description Probes/Genes SMA IHC Disease smooth muscle tumorsSMA is a sensitive marker of myoepithelial
ADH-5
Immunohistochemistry (IHC)ADH-5 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes ADH5 IHC Disease Breast CancerADH-5 simultaneously tests for 5 key markers (CK5/14, p63 and CK7/18) of breast disease in one simple
AFB
Special StainsAFB Alternative Name Acid Fast Bacillus Methodology Special Stains Test Description Probes/Genes MC AFB Disease Acid Fast BacteriaMycobacterial IHC was well adopted with superior clinical performance to
Alcian Blue
Special StainsAlcian Blue Methodology Special Stains Test Description Probes/Genes AB W/H SS Disease Barrett’s esophagus, as it will also stain goblet cells. mesothelioma, atherosclerosis and adenocarcinomas.Alcian
Alcian Blue/PAS
Special StainsAlcian Blue/PAS Methodology Special Stains Test Description Probes/Genes AB W/H SS Disease Connective and epithelial tissue tumorsAlcian blue may be used in combination with the PAS staining procedure,
ALK D5F3 Lung Cancer
Immunohistochemistry (IHC)ALK D5F3 Lung Cancer Methodology Immunohistochemistry (IHC) Test Description Probes/Genes ALK D5F3 IHC Disease Non-Small Cell Lung CancerScreening for anaplastic lymphoma kinase (ALK) rearrangements is
ALK-1 Lymphoma by IHC
Immunohistochemistry (IHC)ALK-1 Lymphoma by IHC Methodology Immunohistochemistry (IHC) Test Description Probes/Genes ALK1 IHC Disease Anaplastic Large Cell LymphomaALK-1 recognizes varying degrees of ALK expression in both the
Alpha Feto Protein
Immunohistochemistry (IHC)Alpha Feto Protein Alternative Name Alpha-1-Fetoprotein (AFP) Methodology Immunohistochemistry (IHC) Test Description Probes/Genes AFP IHC Disease Hepatocellular carcinoma, yolk sac tumor, testicular and
Amyloid A
Immunohistochemistry (IHC)Amyloid A Methodology Immunohistochemistry (IHC) Test Description Probes/Genes Amyloid A IHC Disease AmyloidosisAmyloid A reacts with amyloid deposits in tissues. When accompanied by special stain Congo
Annexin A1
Immunohistochemistry (IHC)Annexin A1 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes ANXA1 IHC Disease Hairy cell leukemiaAnnexin A1 is used to differentiate hairy cell leukemia from other B-cell lymphomas
Arginase-1
Immunohistochemistry (IHC)Arginase-1 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes ARG1 IHC Disease Hepatocellular Carcinoma (HCC)Arginase-I is a key urea cycle metalloenzyme that has been used as an immunohistochemistry
B72.3 (TAG 72)
Immunohistochemistry (IHC)B72.3 (TAG 72) Methodology Immunohistochemistry (IHC) Test Description Probes/Genes B72.3 IHC Disease Most adenocarcinomasTumor-Associated Glycoprotein 72 (TAG-72) is an oncofetal mucin antigen expressed
BCA-225
Immunohistochemistry (IHC)BCA-225 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes BCA225 IHC Disease Breast CancerBCA-225 (Breast Cancer Antigen 225) is a 225 kD glycoprotein present in human breast carcinoma
BCL1
Immunohistochemistry (IHC)BCL1 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes BCL1 IHC Disease MCL (mantle cell lymphoma), Hairy cell leukemia and plasmacytomaBCL1/Cyclin D1 is a nuclear protein detectable
BCL-1 (Cyclin D1)
Immunohistochemistry (IHC)BCL-1 (Cyclin D1) Methodology Immunohistochemistry (IHC) Test Description Probes/Genes BCL1 IHC Disease MCL (mantle cell lymphoma), Hairy cell leukemia and plasmacytomaCyclin D1, a protein of 36 kD, is
BCL2
Immunohistochemistry (IHC)BCL2 Methodology Immunohistochemistry (IHC) Test Description Probes/Genes BCL2 IHC Disease Lymphoma (folicular, Diffuse Large Cell Lymphoma), bone cancer and stomach cancer.BCL-2 (B-cell lymphoma 2), encoded
